GlobeNewsWire · GTLL · October 25, 2026

BioNTech and Bristol Myers Squibb Report Encouraging Global Phase 2 Data for Pumitamig in Advanced NSCLC After Progression on Immunotherapy Plus Chemotherapy

Get the app for more

Explore stock news, insights and company research.